Paper
RSC Advances
indicating the importance of determining the cytotoxicity of the
new AzF4-PhePhe 3 dipeptide and comparing it to our previ-
ously reported dipeptide Az-PhePhe 1.12 In a typical experiment,
Madin-Darby Canine Kidney (MDCK) cells were exposed AzF4-
PhePhe 3 for 24 or 48 hours, and cell viability determined at
concentrations up to 1.7 mM (Fig. 6). The experiments were
conducted under standard solution phase (see experimental
section for details), therefore mimicking dipeptide that would
leach from the hydrogel in a biological setting. The cell viability
was compared to control cells (without 3). Substantial cytotox-
icity of AzF4-PhePhe 3 (cell viability # 50%) was observed at
concentrations of 1.7 mM and 0.43–1.7 mM in the 24 and 48
hour incubation experiments, respectively. As a comparison,
our reported hydrogel Az-PhePhe 1, showed substantial cyto-
toxicity to MDCK cells at a concentration of 1 mM aer 24 hours
of incubation.12 The data suggests that while the differences in
cytotoxicity between are relatively small, the uorinated dipep-
tide 3 exhibits lower cytotoxicity than the non-uorinated
dipeptide 1.
Conflicts of interest
There are no conicts of interest to declare.
Acknowledgements
This research was supported in part by a contract from the
Health Research Council of New Zealand (A. B. G.). We thank
the Department of Chemistry at the University of Otago for use
of the NMR and HRMS instruments, and the Otago Micro and
Nanoscale Imaging for use of their facilities.
Notes and references
1 S. Fleming and R. V. Ulijn, Chem. Soc. Rev., 2014, 43, 8150–
8177.
2 X. Du, J. Zhou, J. Shi and B. Xu, Chem. Rev., 2015, 115, 13165–
13307.
3 M. J. Webber, E. A. Appel, E. W. Meijer and R. Langer, Nat.
Mater., 2016, 15, 13–26.
4 J. Raeburn, A. Zamith Cardoso and D. J. Adams, Chem. Soc.
Rev., 2013, 42, 5143–5156.
4 Conclusion
In summary, the use of a self-immolative 4-azido-2,3,5,6-
tetrauorobenzyl carbamate linker to protect (cap) the N-
terminus of a diphenylalanine dipeptide 2 and generate
a stimuli-responsive hydrogel is reported. The capped dipeptide
(AzF4-PhePhe 3) resulted in a hydrogel that formed a stable
brous network in water, but not in phosphate buffered saline
(PBS). In water (nal pH of 3.7), 3 formed a weak hydrogel at
0.05 wt%, and a strong hydrogel, as evidenced by its viscoelastic
properties, at 0.1 wt% of 3 (considered the critical gel concen-
5 J. Hoque, N. Sangaj and S. Varghese, Macromol. Biosci., 2019,
19, 1800259, DOI: 10.1002/mabi.201800259.
6 S.-M. Hsu, Y.-C. Lin, J.-W. Chang, Y.-H. Liu and H.-C. Lin,
Angew. Chem., Int. Ed., 2014, 53, 1921–1927.
7 W. Liyanage and B. L. Nilsson, Langmuir, 2016, 32, 787–799.
8 D. M. Ryan, S. B. Anderson and B. L. Nilsson, So Matter,
2010, 6, 3220–3231.
9 D. M. Ryan, S. B. Anderson, F. T. Senguen, R. E. Youngman
and B. L. Nilsson, So Matter, 2010, 6, 475–479.
tration). The absence of a hydrogel in PBS (nal pH 3.9) was 10 F.-Y. Wu, S.-M. Hsu, H. Cheng, L.-H. Hsu and H.-C. Lin, New
likely due to disruption of H-bonding and other interactions by J. Chem., 2015, 39, 4240–4243.
the phosphate salts, as reported by others.18 Reaction of the 11 S.-M. Hsu, J.-W. Cheng, F.-Y. Wu, Y.-C. Lin, T.-S. Lai,
AzF4-PhePhe 3 hydrogel with TCO resulted in dissolution of the H. Cheng and H.-C. Lin, RSC Adv., 2015, 5, 32431–32434.
hydrogel in 4–24 hours. At the lowest concentration tested 12 S. Dadhwal, J. M. Fairhall, S. K. Goswami, S. Hook and
(1 mM TCO), the complete visual dissolution took 24 hours. A. B. Gamble, Chem.–Asian J., 2019, 14, 1143–1150.
Encapsulation of doxorubicin (DOX) as a model drug cargo was 13 S. S. Matikonda, J. M. Fairhall, F. Fiedler, S. Sanhajariya,
conducted at 0.1 wt% of 3, and upon addition of TCO (1 mM)
dissolution resulted in 76% and 89% release of DOX aer 10
R. A. J. Tucker, S. Hook, A. L. Garden and A. B. Gamble,
Bioconjugate Chem., 2018, 29, 324–334.
¨
and 24 hours, respectively. The rate of the 1,3-dipolar cycload- 14 M. Sundhoro, S. Jeon, J. Park, O. Ramstrom and M. Yan,
dition between an AzF4-PhePhe 3 and TCO was determined Angew. Chem., Int. Ed., 2017, 56, 12117–12121.
under pseudo rst-order conditions in solution phase, and the 15 Y. Xie, L. Cheng, Y. Gao, X. Cai, X. Yang, L. Yi and Z. Xi,
second-order rate constant calculated as 0.095 ꢃ 0.010 Mꢂ1 sꢂ1
,
Chem.–Asian J., 2018, 13, 1791–1796.
16 S. S. Matikonda, D. L. Orsi, V. Staudacher, I. A. Jenkins,
F. Fiedler, J. Chen and A. B. Gamble, Chem. Sci., 2015, 6,
1212–1218.
ve-times faster than the reaction of TCO with Az-PhePhe 1.12
The ability to formulate AzF4-PhePhe 3 as a stable hydrogel at
0.1 wt%, and its improved sensitivity and rate of reaction with
the bioorthogonal trigger (TCO), indicates that the use of uo- 17 M. Royzen, G. P. A. Yap and J. M. Fox, J. Am. Chem. Soc., 2008,
rine in related peptide-based hydrogels could lead to drug 130, 3760–3761.
delivery systems with in vivo potential. Other endogenous trig- 18 D. M. Ryan, T. M. Doran, S. B. Anderson and B. L. Nilsson,
gers of azides, for example hydrogen sulde, explored by others Langmuir, 2011, 27, 4029–4039.
on short peptidic hydrogels,25 would also provide an alternate 19 D. M. Ryan, T. M. Doran and B. L. Nilsson, Langmuir, 2011,
strategy for dissolution of hydrogels with uorinated aryl azide- 27, 11145–11156.
capping groups. Peptidic and polymeric hydrogels incorpo- 20 D. M. Ryan, T. M. Doran and B. L. Nilsson, Chem. Commun.,
rating the tetrauoroaryl azide and other azide-functionalised 2011, 47, 475–477.
self-immolative linkers, and their activation mechanisms are 21 S. Debnath, S. Roy, Y. M. Abul-Haija, P. W. J. M. Frederix,
of current interest to our research group.
S. M. Ramalhete, A. R. Hirst, N. Javid, N. T. Hunt,
This journal is © The Royal Society of Chemistry 2020
RSC Adv., 2020, 10, 9234–9244 | 9243